{"id":"W2890138337","doi":"10.1200/jco.2021.39.15_suppl.4532","title":"Pembrolizumab (pembro) versus investigator’s choice of paclitaxel, docetaxel, or vinflunine in recurrent, advanced urothelial cancer (UC): 5-year follow-up from the phase 3 KEYNOTE-045 trial.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval","funders":"","keywords":"Docetaxel; Medicine; Regimen; Internal medicine; Randomization; Clinical trial; Phases of clinical research; Oncology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004584127,0.001341194,0.001695627,0.0004721757,0.000430909,0.001068285,0.000882251,0.001632233,0.005941469],"category_scores_gemma":[0.002370518,0.0005469264,0.002187572,0.0004170086,0.0007701842,0.001310907,0.0005646454,0.003204588,0.0009325049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001307983,"about_ca_system_score_gemma":0.001085605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009814225,"about_ca_topic_score_gemma":0.002370529,"domain_scores_codex":[0.9990722,0.0005183223,0.00006203319,0.0001205072,0.00006850321,0.0001584496],"domain_scores_gemma":[0.9987121,0.0003290767,0.0003953868,0.0001042814,0.00004859342,0.000410598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9695584,0.00739823,0.001267985,0.0003062503,0.0009080243,0.00003299879,0.00004751848,0.0005984225,0.001573959,0.00006662487,0.001634929,0.01660666],"study_design_scores_gemma":[0.814894,0.1718338,0.008440613,0.00006445467,0.001233904,0.00007608406,0.00003197891,0.0008163562,0.0007334703,0.000222013,0.001633378,0.00001986881],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846643,0.00520628,0.0006174726,0.0007548087,0.0003130429,0.002816739,0.002681653,0.00008450969,0.002861198],"genre_scores_gemma":[0.9885889,0.001658244,0.0007162676,0.001105285,0.0002828884,0.002224249,0.002655759,0.00002233509,0.002746076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005941469,"threshold_uncertainty_score":0.02424353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2242483104486075,"score_gpt":0.5124252516500166,"score_spread":0.2881769412014091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}